Drugs / H5N1 Pandemic Influenza Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00376402 | Oct 2006 → Jun 2007 | influenza | Seqirus | Completed | No outcome recorded |
| Phase 2 | NCT00370864 | Sep 2006 → Jul 2007 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H5N1 pandemic influenza vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00370864 ↗ |
| Modality | Vaccine | “prototype inactivated, aluminium adjuvanted, split-virus, clade 1 H5N1 vaccine” PMID 18801398 ↗ Sep 2008 |